Biotechnology
Medison Pharma Announces Expansion of the Multi-Territorial Agreement with Immunocore into Latin America
With this latest expansion, Medison's global footprint is now extended across Israel, Central and Eastern Europe, Canada, Asia-Pacific and Latin America, offering patients in international markets improved access to highly innovative therapies. PETACH TIKVAH, Israel, Nov. 9, 2022 /PRNewswire/ --...
2022-11-09 23:32
2442
Transcenta to Hold 3 Exchange Sessions on Post-SITC Business Update Call & TST003 data release and pipeline development progress update
SUZHOU, China, Nov. 9, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical-stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development, and manufacturing of antibody-based therapeutics, announces that the management ...
2022-11-09 21:09
3063
Strong business performance in 9M/2022: Exyte increases order intake, sales, and profitability
* Order intake up by more than 25% year-on-year, marking a new 9M-high with €6.5 billion * Sales volume increased by almost 60% to €5.3 billion * Strong increase in sales in all three business segments * Adjusted EBIT increased by 73% to €308 million; adjusted EBITDA rose by 70% to €340 mi...
2022-11-09 18:40
2618
Siemens Healthineers to demonstrate the remote capabilities of Corindus CorPath GRX Robotic System using Mentice VIST ® Simulator
GOTHENBURG, Sweden, Nov. 9, 2022 /PRNewswire/ -- Mentice, a world leader in simulation solutions for image-guided interventional therapies, announced today that Siemens Healthineers China is showcasing the remote capabilities of the Corindus CorPath GRX Robotic PCI system by using the Mentice VIS...
2022-11-09 16:52
2557
TES Pharma Congratulates Intercept Pharmaceuticals on their Presentation of Phase 1 INT-787 Data at the AASLD Meeting and the Initiation of the Phase 2a FRESH Study in Patients with Severe Alcohol-Associated Hepatitis
INT-787 is a selective next generation FXR agonist invented by TES Pharma and licensed to Intercept Pharmaceuticals INT-787 has shown strong anti-fibrotic and anti-inflammatory effects in animal models TES Pharma is dedicated to the identification of novel therapeutic targets and the discovery ...
2022-11-09 06:00
1948
Himalaya Therapeutics Announces Highlights of Recent Clinical Progress
* Mecbotamab vedotin (BA3011) Phase 2 part 1 interim results in NSCLC continue to show antitumor activity with additional patients enrolled * HTBA3011 Undifferentiated Pleomorphic Sarcoma (UPS) enrollment in Phase 2 part 2 of study anticipated to begin by year-end * CAB-CTLA-4 (HTBA3071) Pha...
2022-11-08 23:08
2212
Novavax Phase 3 COVID-19 Omicron Trial Supports the Continued and Future Use of Novavax Prototype Vaccine as a Booster
* The Novavax BA.1 vaccine candidate met its primary strain-change endpoint allowing for development of variant vaccines, if necessary * Novavax' prototype vaccine induced broad immune response against original Wuhan, BA.1, and BA.5 strains * The trial showed no benefit for a bivalent vaccin...
2022-11-08 21:00
2834
MGI Partners with ALACRiS Theranostics to Open New Customer Experience Center in Germany
BERLIN, Nov. 8, 2022 /PRNewswire/ -- MGI, a company committed to building core tools and technology to lead life science, today announced the launch of its new Customer Experience Center (CEC) inBerlin, Germany. The CEC is located at ALACRiS Theranostics GmbH (ALACRiS)'s facility. ALACRiS Therano...
2022-11-08 19:37
1380
EIT Health's Venture Centre of Excellence Names ProductLife Group as Privileged Partner for Regulatory & Compliance
* The ambitious EU initiative has already secured 2 billion euros of co-investment capabilities and has supported 60 innovative Biotech, Medtech & digital health start-ups to get to market or expand into new territories. * EIT Health, co-operator of the Venture Centre of Excellence alongside t...
2022-11-08 16:00
2039
BIORCHESTRA announces that BMD-001 reduces Amyloid-β and Tau in non-human primate animal model of Alzheimer's Disease at the RNA Leaders USA Conference in Boston
BOSTON, Nov. 8, 2022 /PRNewswire/ -- Dr. Branden Ryu, CEO and Founder of BIORCHESTRA Ltd. (S. Korea), was a featured speaker at a plenary session of the RNA Leaders CongressUSA in Boston, MA, on October 18th, 2022. Dr Ryu focused on the new efficacy data of their leading compound,BMD-001, derived...
2022-11-08 15:59
1567
BIORCHESTRA announces that BMD-001 reduces Amyloid-β and Tau in non-human primate animal model of Alzheimer's Disease at the RNA Leaders USA Conference in Boston
BOSTON, Nov. 8, 2022 /PRNewswire/ -- Dr. Branden Ryu, CEO and Founder of BIORCHESTRA Ltd. (S. Korea), was a featured speaker at a plenary session of the RNA Leaders CongressUSA in Boston, MA, on October 18th, 2022. Dr Ryu focused on the new efficacy data of their leading compound,BMD-001, derived...
2022-11-08 15:30
1570
Osteopore's Breakthrough Natural Tissue Regeneration Technology Leaps into Global Spotlight
The global leader's innovative regenerative medical technology and devices
vastly improve patient outcomes and reduce overall medical costs.
SINGAPORE, Nov. 8, 2022 /PRNewswire/ -- Osteopore International
2022-11-08 09:11
2237
Cyagen and Neurophth Enter Global Strategic Collaboration to Develop AI-Designed AAV Gene Therapy Vectors for Ophthalmic Disorders
SANTA CLARA, Calif., Nov. 8, 2022 /PRNewswire/ -- Cyagen today announced a
strategic collaboration with Neurophth Therapeutics, Inc. to co-develop
next-generation AAV gene therapy vectors for specific types of genetic
ophthalmic disorders.
2022-11-08 08:00
1866
Sophie's BioNutrients Debuts Chlorella Ice Cream to Storm the Vegan Ice Cream Industry
Sophie's BioNutrients introduces sustainable and nutritious ice cream with
double the action for the sweet tooth.
WAGENINGEN, Netherlands, Nov. 7, 2022 /PRNewswire/ -- Sophie's BioNutrients
2022-11-07 23:39
2538
Brexogen's Exosome Therapy for Atopic Dermatitis, 'BRE-AD01' Accepted for Phase 1 Clinical Trials by US FDA
First entry to clinical trial of exosome for atopic dermatitis The first exosome-based therapeutics in US clinical trial among Korean companies SEOUL, South Korea, Nov. 7, 2022 /PRNewswire/ -- The US FDA granted the initiation of the phase 1 clinical trial of 'BRE-AD01', an exosome- based ther...
2022-11-07 07:00
1829
Telix Announces Positive Topline Results of ZIRCON Phase III Kidney Cancer Imaging Study
Summary of Study Outcomes * ZIRCON Phase III study of Telix's investigational imaging agent TLX250-CDx in clear cell renal cell carcinoma (ccRCC) has met all of its primary and secondary endpoints * The study delivered co-primary endpoints of 86% sensitivity and 87% specificity and 93% posit...
2022-11-07 06:48
1635
TurtleTree to Represent Singapore at UN Climate Change Conference 2022 as Official Drink Partner
SHARM EL-SHEIKH, Egypt and SINGAPORE, Nov. 5, 2022 /PRNewswire/ -- TurtleTree
will beSingapore's official drink partner at this year's UN Climate Change
Conference(COP27), taking place from 6 to 18 November in Sharm El-Sheikh, Egypt.
2022-11-05 02:53
3451
NSW Health & Cicada Innovations celebrate Australia's biggest health startup training program with 1.1k participants in first year
SYDNEY, Nov. 4, 2022 /PRNewswire/ -- The NSW Health Commercialisation Training
Program
2022-11-04 11:35
2451
LUMC to Fund New Clinical Trial of Cynata's Cymerus™ MSCs in Kidney Transplantation
Key Highlights: * Cynata to collaborate with Leiden University Medical Center (LUMC) in the Netherlands, in a new clinical trial in patients who have received a kidney transplant * Trial to be funded by LUMC; Cynata will supply iPSC-derived Cymerus mesenchymal stem cells (MSCs) at its cost t...
2022-11-04 09:15
2619
Aquavit Celebrates Judgment Imposing Permanent Ban On Counterfeiters
NEW YORK, Nov. 4, 2022 /PRNewswire/ -- Aquavit Pharmaceuticals, Inc. ("Aquavit") secured a long-awaited and much-deserved judgment against counterfeiters. After nearly four years of court proceedings, the Honorable Valerie E. Caproni ofthe United States District Court for the Southern District o...
2022-11-04 01:37
2680
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 290 media titles]
2024-04-22 16:00
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 289 media titles]
2024-04-22 06:00
With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
[Picked up by 287 media titles]
2024-04-18 21:26
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
[Picked up by 286 media titles]
2024-04-19 13:25
Animated Life in Yunnan
[Picked up by 281 media titles]
2024-04-18 14:00
Most Read
Combining Sustainability and Cybersecurity: Century Iron & Steel and Century Wind Power Both Receive ISO 27001 Information Security Certification
2024-04-19 18:03
7882
With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
2024-04-18 21:26
7811
Animated Life in Yunnan
2024-04-18 14:00
7781
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
2024-04-19 13:25
6155
IQAX eBL Wins Prestigious APTFF Trade Facilitation Innovation Award 2024
2024-04-18 10:36
3865